Skip to main content
Premium Trial:

Request an Annual Quote

Roche Licenses Gene Polymorphism for AmpliChip Test from Epidauros

NEW YORK, Nov. 10 (GenomeWeb News) - Epidauros Biotechnologie has licensed a genetic polymorphism to Roche Molecular Systems to include in its AmpliChip CYP450 test, the Bernried, Germany-based company said last week.

 

Under the non-exclusive license, Roche can use a polymorphism of the promoter region of the CYP2D6 gene in discovery, production, and commercialization of the AmpliChip.

 

Roche will make an upfront payment to Epidauros and pay the company royalties on sales of the AmpliChip CYP450 test, which is currently available in the European Union. Roche has said in the past that it intends to file the product for approval in the United States.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.